Lv11
30 积分 2024-08-17 加入
Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: a systematic review and meta-analysis
10小时前
求助中
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
3天前
已完结
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
5天前
已完结
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies
12天前
已完结
Emerging biologic therapies for systemic lupus erythematosus
26天前
已完结
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
1个月前
已完结
皖公网安备34019202002308
